GemPharmatech (688046.SH) shareholder Qingdao National Pharmaceutical reduced its holdings by 888,200 shares, decreasing its stake to 5%.
Yaokang Biopharmaceuticals (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao Guoyao Daichuang...
GemPharmatech (688046.SH) announced on September 24, 2024, that its shareholder Qingdao Guoyao DaChuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has reduced its shareholding in the company by 888,200 shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, Qingdao Guoyao holds a reduced stake of 5% in the company.
Related Articles
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.
US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%
US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.
US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%
US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
RECOMMEND
Rare Sales Decline for Tank Brand—How Will Great Wall Motor Defend Its Market Position?
14/07/2025
Inside the Explosive Growth of the New Tea Beverage Sector: Supply Chains, Innovation, and Cultural Capital
14/07/2025
Hafu Securities Joins the Race as Hong Kong Accelerates Its Push to Become a Virtual Asset Hub
14/07/2025
